Lung cancer is the most common cause of cancer-associated death worldwide. Postoperative relapse and subsequent metastasis result in a high mortality rate, even in early stage lung cancer. MicroRNAs (miRNAs) are small non-coding RNAs that regulate gene expression at the post-transcriptional level and are frequently dysregulated in various cancers. The aim of this study was to identify recurrence-associated miRNAs in early stage lung cancer. To screen for differentially expressed miRNAs related to postoperative recurrence, miRNA microarray data derived from stage I lung adenocarcinoma formalin-fixed paraffin-embedded (FFPE) tissue samples (n=6) and publically available the Cancer Genome Atlas (TCGA) data were analyzed. An independent sample ...
Lung cancer is the major human malignancy, accounting for 30 % of all cancer-related deaths worldwid...
Breast cancer is a heterogeneous disease, and patients with the luminal subtype have a range of outc...
Breast cancer is a heterogeneous disease, and patients with the luminal subtype have a range of outc...
Background:Despite undergoing curative resection, nearly a third of patients with stage I non-small ...
Relapse of adenocarcinoma, the most common non-small cell lung cancer (NSCLC), is a major clinical c...
Relapse of adenocarcinoma, the most common non-small cell lung cancer (NSCLC), is a major clinical c...
Lung cancer is the leading cause of cancer-related death worldwide, and the majority of cases (77%) ...
Lung cancer is the first cause of cancer death in the world due to its high prevalence, aggressivene...
Abstract Carcinoma of the lung is among the most common types of cancer globally. Concerning its his...
Lung cancer is the major human malignancy, accounting for 30% of all cancer-related deaths worldwide...
Background: MicroRNAs (miRNAs) play an important role in the regulation of cell proliferation, apopt...
<div><p>Lung cancer is the major human malignancy, accounting for 30% of all cancer-related deaths w...
Abstract:Lung cancer is the leading cause of cancer related deaths in the United States. It is estim...
SummaryMicroRNA (miRNA) expression profiles for lung cancers were examined to investigate miRNA's in...
ObjectivesMicroRNAs (miRNAs) are widely known for their function as regulators of gene expression vi...
Lung cancer is the major human malignancy, accounting for 30 % of all cancer-related deaths worldwid...
Breast cancer is a heterogeneous disease, and patients with the luminal subtype have a range of outc...
Breast cancer is a heterogeneous disease, and patients with the luminal subtype have a range of outc...
Background:Despite undergoing curative resection, nearly a third of patients with stage I non-small ...
Relapse of adenocarcinoma, the most common non-small cell lung cancer (NSCLC), is a major clinical c...
Relapse of adenocarcinoma, the most common non-small cell lung cancer (NSCLC), is a major clinical c...
Lung cancer is the leading cause of cancer-related death worldwide, and the majority of cases (77%) ...
Lung cancer is the first cause of cancer death in the world due to its high prevalence, aggressivene...
Abstract Carcinoma of the lung is among the most common types of cancer globally. Concerning its his...
Lung cancer is the major human malignancy, accounting for 30% of all cancer-related deaths worldwide...
Background: MicroRNAs (miRNAs) play an important role in the regulation of cell proliferation, apopt...
<div><p>Lung cancer is the major human malignancy, accounting for 30% of all cancer-related deaths w...
Abstract:Lung cancer is the leading cause of cancer related deaths in the United States. It is estim...
SummaryMicroRNA (miRNA) expression profiles for lung cancers were examined to investigate miRNA's in...
ObjectivesMicroRNAs (miRNAs) are widely known for their function as regulators of gene expression vi...
Lung cancer is the major human malignancy, accounting for 30 % of all cancer-related deaths worldwid...
Breast cancer is a heterogeneous disease, and patients with the luminal subtype have a range of outc...
Breast cancer is a heterogeneous disease, and patients with the luminal subtype have a range of outc...